Samsara BioCapital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $3.84M | Hold |
|
|||||
|
2024
Q2 | $9.22M | Hold |
|
|||||
|
2024
Q1 | $9.56M | Hold |
|
|||||
|
2023
Q4 | $13.9M | Buy |
|
|||||
|
2023
Q3 | $3.48M | Hold |
|
|||||
|
2023
Q2 | $2.78M | Hold |
|
|||||
|
2023
Q1 | $2.35M | Hold |
|
|||||
|
2022
Q4 | $3.16M | Hold |
|
|||||
|
2022
Q3 | $5.68M | Buy |
|
|||||
|
2022
Q2 | $1.83M | Hold |
|
|||||
|
2022
Q1 | $2.26M | Sell |
|
|||||
|
2021
Q4 | $6.24M | Hold |
|
|||||
|
2021
Q3 | $8.62M | Hold |
|
|||||
|
2021
Q2 | $10.6M | Hold |
|
|||||
|
2021
Q1 | $14.8M | Hold |
|
|||||
|
2020
Q4 | $21.8K | Buy |
|
|||||
|
2020
Q3 | $11.6M | Sell |
|
|||||
|
2020
Q2 | $15.9M | Sell |
|
|||||
|
2020
Q1 | $9.6M | Hold |
|
|||||
|
2019
Q4 | $11.3M | Hold |
|
|||||
|
2019
Q3 | $17M | Hold |
|
|||||
|
2019
Q2 | $15.2M | Buy |
|
|||||
|
2019
Q1 | $9.69M | Hold |
|
|||||
|
2018
Q4 | $5.9M | Buy |
|